Retatrutide
Synthetic peptide studied in clinical and preclinical models for body weight reduction and increased energy expenditure
Last updated: March 1, 2026
- Compound
- Retatrutide
- Class
- Body Composition peptide
- Summary
- Synthetic peptide studied in clinical and preclinical models for body weight reduction, increased energy expenditure, hepatic fat reduction.
- Mechanism
- Glucose-Dependent Insulin Modulation
- Research Status
- Phase III
- Routes Studied
- Subcutaneous injection via auto-injector pen
- Evidence Level
- Late-stage clinical · Clinically tested
What Should You Know About Retatrutide?
- What is Retatrutide?
- Retatrutide is a synthetic peptide studied in clinical and preclinical models for body weight reduction and increased energy expenditure.
- Is Retatrutide clinically proven?
- No. Human evidence remains limited and does not establish Retatrutide as clinically proven.
- What has Retatrutide been studied for?
- Retatrutide has been studied in clinical and preclinical settings of body weight reduction, increased energy expenditure, hepatic fat reduction. Late-stage clinical trials have been conducted, though final regulatory outcomes may vary by jurisdiction.
- Is Retatrutide approved?
- Retatrutide is in late-stage clinical development but has not yet received full regulatory approval in all jurisdictions. Consult a local specialist for current status.
What Is Retatrutide?
Retatrutide (LY3437943) is a novel synthetic peptide engineered as a triple agonist targeting three distinct incretin and metabolic hormone receptors simultaneously: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). This tri-agonist approach represents a significant advancement beyond single-receptor (GLP-1 only) and dual-receptor (GIP/GLP-1) agonist compounds, engaging three complementary metabolic pathways that collectively govern energy intake, energy expenditure, and substrate metabolism.
Evidence Summary
Retatrutide has reached late-stage clinical trials (Phase III). Substantial human data exists, though final regulatory outcomes may still be pending.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Body Weight Reduction | Limited |
| Increased Energy Expenditure | Limited |
| Hepatic Fat Reduction | Limited |
| Cardiometabolic Improvement | Limited |
| Human clinical evidence | Substantial |
| Safety data | Insufficient |
Editorial Position
Retatrutide is best understood as a compound with emerging clinical evidence that has not yet reached definitive conclusions. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Late-stage clinical trials conducted; not yet approved in all jurisdictions
- Safety data from clinical trials available but regulatory review ongoing
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Retatrutide is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Retatrutide Been Studied For?
Research areas where Retatrutide has been investigated in published studies
-
Body Weight Reduction Retatrutide has been studied in clinical and preclinical studies of body weight reduction.
-
Increased Energy Expenditure Retatrutide has been studied in clinical and preclinical studies of increased energy expenditure.
-
Hepatic Fat Reduction Retatrutide has been studied in clinical and preclinical studies of hepatic fat reduction.
-
Cardiometabolic Improvement Retatrutide has been studied in clinical and preclinical studies of cardiometabolic improvement.
How Does Retatrutide Work?
These mechanisms have been studied in clinical and preclinical settings. Clinical trials are ongoing or completed.
- 01 Triple Receptor Engagement
- 02 Central Appetite Suppression
- 03 Glucagon-Mediated Thermogenesis
- 04 Enhanced Lipolysis & Fat Oxidation
Not sure if Retatrutide is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Retatrutide.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Retatrutide
How Is Retatrutide Administered?
Retatrutide is available via Subcutaneous injection via auto-injector pen. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Retatrutide?
What Conditions Has Retatrutide Been Linked To?
Have Questions About Retatrutide?
Published studies on Retatrutide can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Retatrutide is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
A qualified specialist experienced with peptide therapies can help you understand the current evidence and determine suitability.
Ready to discuss Retatrutide with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026